Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Ms Mattu Kroma

Research Student - MPhil/PhD - Infectious & Tropical Diseases

United Kingdom

Jump to: Affiliations Publications

Affiliations
Department of Infection Biology
Faculty of Infectious and Tropical Diseases

Selected Publications
Characterisation of the First Complete Dengue Genome in Sierra Leone
Campbell, AK O; Omah, I; Diouf, AM; Ndiaye, M; Campbell, JS O; Parker, E; Folorunso, V; Williams, AJ; KROMA, MT; Mani, SY; Daniel-Sesay, N; Souma, Z; Miller, C; Lansana, R; Kargbo, AM; Chalobah, F; Cisse, M; Jallow, MM; Charles, J; Koroma, AT; Kanu, JS; Kebede, A; Tanui, C; Tessema, S; Faye, O; ... Diallo, B.
2026
Viruses
Setting Up a Quality-managed Laboratory for Clinical Vaccine Trials During Public Health Emergencies in a Resource-constrained Setting: The Sierra Leone Experience.
Lawal, B; Faye, F; Otieno, G; KROMA, M; DRAMMEH, A; Fangawa, J; Koroma, F; Turay, AS; Kamara, J-P; Lowe, B; Leigh, B; Samai, M; GREENWOOD, B; WATSON-JONES, D;
2025
UK Clinical Vaccine network
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone.
CHOI, EM-L; Lacarra, B; AFOLABI, MO; Ale, BM; Baiden, F; Bétard, C; Foster, J; Hamzé, B; Schwimmer, C; Manno, D; D'Ortenzio, E; Ishola, D; Keita, CM; Keshinro, B; Njie, Y; Van Dijck, W; Gaddah, A; Anumendem, D; Lowe, B; Vatrinet, R; Lawal, BJ; Otieno, GT; Samai, M; Deen, GF; Swaray, IB; ... EBOVAC-3/EBL2005 Study Team,
2023
The Lancet Global health
The effect of malaria infection on the immune response to the two-dose Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen in adults and children enrolled in a vaccine trial in Sierra Leone
MANNO, D; AYIEKO, P; Ishola, D; AFOLABI MBBS, MPH, PHD, FWACP, FHEA, FFPH, M; Baiden, F; TINDANBIL, D; Abu Bakarr, K; Bah, OM; Rogers, B; Owusu-Kyei, K; DRAMMEH, A; PATTERSON, C; Tetteh, K; KROMA, MT; Otieno, GT; Lawal, B; Gaddah, A; Deen, GF; Keshinro, B; Njie, Y; Kowuor, D; Lowe, B; Robinson, C; Leigh, B; DRAKELEY, C; ... WATSON-JONES, D.
2023
17TH VACCINE CONGRESS
The Effect of Previous Exposure to Malaria Infection and Clinical Malaria Episodes on the Immune Response to the Two-Dose Ad26.ZEBOV, MVA-BN-Filo Ebola Vaccine Regimen.
MANNO, D; PATTERSON, C; DRAMMEH, A; TETTEH, K; KROMA, MT; Otieno, GT; Lawal, BJ; SOREMEKUN, S; AYIEKO, P; Gaddah, A; Kamara, AB; Baiden, F; AFOLABI, MO; TINDANBIL, D; Owusu-Kyei, K; Ishola, D; Deen, GF; Keshinro, B; Njie, Y; Samai, M; Lowe, B; Robinson, C; Leigh, B; DRAKELEY, C; GREENWOOD, B; ... WATSON-JONES, D.
2023
Vaccines
Safety and immunogenicity of an Ad26.ZEBOV booster dose in children previously vaccinated with the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen: an open-label, non-randomised, phase 2 trial.
MANNO, D; Bangura, A; Baiden, F; Kamara, AB; AYIEKO, P; Kallon, J; Foster, J; Conteh, M; CONNOR, NE; Koroma, B; Njie, Y; Borboh, P; Keshinro, B; Lawal, BJ; KROMA, MT; Otieno, GT; Deen, AT; CHOI, EM-L; BALAMI, AD; Gaddah, A; McLean, C; Luhn, K; Adetola, HH; Deen, GF; Samai, M; ... WATSON-JONES, D.
2022
The Lancet. Infectious diseases
Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols.
Baiden, F; FLECK, S; Leigh, B; AYIEKO, P; TINDANBIL, D; Otieno, T; Lawal, B; Tehtor, M; Rogers, M; Odeny, L; Hodges, MH; Sonnie, M; Samai, M; Ishola, D; Lowe, B; WATSON-JONES, D; GREENWOOD, B;
2022
PLoS One
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial.
AFOLABI, MO; ISHOLA, D; MANNO, D; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; Baiden, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; GALLAGHER, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial.
ISHOLA, D; MANNO, D; AFOLABI, MO; Keshinro, B; Bockstal, V; Rogers, B; Owusu-Kyei, K; Serry-Bangura, A; Swaray, I; Lowe, B; Kowuor, D; BAIDEN, F; Mooney, T; Smout, E; Köhn, B; Otieno, GT; Jusu, M; Foster, J; Samai, M; Deen, GF; LARSON, H; LEES, S; Goldstein, N; Gallagher, KE; Gaddah, A; ... EBL3001 study group,
2021
Lancet Infectious Diseases
See more information

Contact

United Kingdom